Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Centene Corp (CNC) vs Progressive Corp (PGR) Price & Performance

Centene CorpTrade
Progressive CorpTrade

Price performance (Past 24H)

Key statistics

Centene Corp vs Progressive Corp — how do they compare? Centene Corp trades at $68.55 (market cap $33.72B), while Progressive Corp trades at $226.53 (market cap $136.51B). The key difference: Progressive Corp is far larger — about 4× Centene Corp's market cap, and Progressive Corp pays a 5.93% dividend while Centene Corp pays none. Which is the better fit depends on your goals.

CNCPGR
Market Cap
$33.72B$136.51B
Sector
HealthFinancials
52-Week High
$68.72$252.68
52-Week Low
$25.21$190.40
Enterprise Value
$26.35B$144.74B
Dividend Yield
5.93%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Centene Corp

Centene Corporation (CNC) trades at $68.29, up 1.4% with strong technical momentum and bullish moving average signals. The stock shows impressive 66% YTD gains, supported by recent contract renewals and margin recovery initiatives. Despite negative 2025 net income of -$6.67B, valuation metrics remain attractive with P/E of 8.06 and P/S of 0.17. Analyst consensus is strongly bullish with 61% buy ratings and $66.07 price target.

Centene presents a compelling value opportunity with low valuation multiples and strong operational cash flow of $5.09B. Key risks include ongoing margin pressure and Medicaid contract dependency. The company's AI-driven cost controls and recent Illinois Medicaid renewal provide catalysts for earnings recovery, though healthcare regulatory changes remain a concern for long-term stability.

Progressive Corp

Progressive (PGR) trades at $234.48, up 1.63% today, near its consensus price target of $240.89. The stock shows strong fundamentals with revenue growth from $49.6B in 2022 to $87.6B in 2025 and a net income margin of 12.93%. Technical indicators are bullish, with the price above key moving averages. Recent news highlights focus on Q2 2026 earnings expectations due July 15, 2026.

Outlook is positive given earnings growth and analyst buy ratings, but risks include potential earnings misses and competitive pressures. The stock offers value with a P/E of 11.93, below industry averages, supporting a bullish view for long-term investors despite near-term volatility.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Centene Corp

Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.

Read more on CNC

About Progressive Corp

Progressive underwrites private and commercial auto insurance and specialty lines

Read more on PGR